Literature DB >> 28448824

A new quantitative method to assess disproportionately enlarged subarachnoid space (DESH) in patients with possible idiopathic normal pressure hydrocephalus: The SILVER index.

Nicola Benedetto1, Carlo Gambacciani2, Filippo Aquila2, Davide Tiziano Di Carlo2, Riccardo Morganti3, Paolo Perrini2.   

Abstract

OBJECTIVES: Preoperative diagnosis of idiopathic normal-pressure hydrocephalus (iNPH) remains challenging. Recently, the presence of disproportionally enlarged subarachnoid spaces and hydrocephalus (DESH) on diagnostic images has been linked to clinical improvement after ventriculoperitoneal (VP) shunt placement. In this study we describe a new quantitative method to assess DESH on CT scans and to evaluate its prognostic value. PATIENTS AND METHODS: A multiplanar reconstruction software was used to retrospectively evaluate prospectively collected radiological data (CT scans) of 26 controls and 29 consecutive patients that underwent VP shunt placement for possible iNPH. The ratio between the areas of the sylvian fissure and the subarachnoid space at the vertex was calculated (SILVER index). The diagnostic accuracy of the SILVER index and the estimate of the best cut-point were assessed using ROC analysis.
RESULTS: The mean value of the SILVER index was 11.52±14.27 in the study group and 1.68±0.98 in the control group (p-value<0.0001). The area under the ROC curve for the SILVER index was 0.903 (95% CI 0.813-0.994). A cut-off value for the SILVER index of 3.75 was extrapolated with a sensitivity and specificity of 0.828 and 0.962 respectively.
CONCLUSIONS: The SILVER index is a reliable tool to easily quantify DESH on CT scans of patients with suspected iNPH. Its high sensitivity and specificity should encourage further investigations in order to confirm its clinical utility.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DESH; Normal pressure hydrocephalus; Tap test; Ventriculoperitoneal shunt

Mesh:

Year:  2017        PMID: 28448824     DOI: 10.1016/j.clineuro.2017.04.015

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery.

Authors:  S Agerskov; M Wallin; P Hellström; D Ziegelitz; C Wikkelsö; M Tullberg
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

2.  Variability of Normal Pressure Hydrocephalus Imaging Biomarkers with Respect to Section Plane Angulation: How Wrong a Radiologist Can Be?

Authors:  P Ryska; O Slezak; A Eklund; J Salzer; J Malm; J Zizka
Journal:  AJNR Am J Neuroradiol       Date:  2021-04-22       Impact factor: 4.966

3.  Brain ventricle parcellation using a deep neural network: Application to patients with ventriculomegaly.

Authors:  Muhan Shao; Shuo Han; Aaron Carass; Xiang Li; Ari M Blitz; Jaehoon Shin; Jerry L Prince; Lotta M Ellingsen
Journal:  Neuroimage Clin       Date:  2019-05-24       Impact factor: 4.881

4.  Distinct volumetric features of cerebrospinal fluid distribution in idiopathic normal-pressure hydrocephalus and Alzheimer's disease.

Authors:  Jaehwan Han; Myoung Nam Kim; Ho-Won Lee; Shin Young Jeong; Sang-Woo Lee; Uicheul Yoon; Kyunghun Kang
Journal:  Fluids Barriers CNS       Date:  2022-09-01

5.  Prognostic Utility of Disproportionately Enlarged Subarachnoid Space Hydrocephalus in Idiopathic Normal Pressure Hydrocephalus Treated with Ventriculoperitoneal Shunt Surgery: A Systematic Review and Meta-analysis.

Authors:  H Y Park; C R Park; C H Suh; M J Kim; W H Shim; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-27       Impact factor: 4.966

Review 6.  Current Updates on Idiopathic Normal Pressure Hydrocephalus.

Authors:  Boon Seng Liew; Kiyoshi Takagi; Yoko Kato; Shyam Duvuru; Sengottuvel Thanapal; Balamurugan Mangaleswaran
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.